26 Comorbidities within 10 years before the treatment initiation were identified through the Danish National Prescription Registry and the Danish National Patient Registry (a list of ATC and diagnosis codes used for definitions is available in Table S2)
10.1136/gut.2004.059741 132
The other C-terminal modifications include additions of Human serum albumin (3 entries), cholesterol (2 entries), PEG (24 entries), XTEN (4 entries), Fc-region (14 entries), etc
Yes, for the vast majority of people
Some users report a brighter appearance after a few sessions, while others may notice gradual improvements over time
Therefore, biosynthesis of nanoparticles not only increases their efficacy and bioavailability but also reduces the dose required